Badi, I., Al-Mahdawi, A. (2025). Manifestations of Neuro-Behcet disease: A case series study. , 24(2), 206-211. doi: 10.52573/ipmj.2025.147297
Israa Ali Badi; Akram Mohammed Al-Mahdawi. "Manifestations of Neuro-Behcet disease: A case series study". , 24, 2, 2025, 206-211. doi: 10.52573/ipmj.2025.147297
Badi, I., Al-Mahdawi, A. (2025). 'Manifestations of Neuro-Behcet disease: A case series study', , 24(2), pp. 206-211. doi: 10.52573/ipmj.2025.147297
Badi, I., Al-Mahdawi, A. Manifestations of Neuro-Behcet disease: A case series study. , 2025; 24(2): 206-211. doi: 10.52573/ipmj.2025.147297

Manifestations of Neuro-Behcet disease: A case series study

Iraqi Postgraduate Medical Journal
Article 9, Volume 24, Issue 2, April 2025, Pages 206-211    PDF (353.6 K)
Document Type: Research Paper
DOI: 10.52573/ipmj.2025.147297
Authors
Israa Ali Badi* 1; Akram Mohammed Al-Mahdawi2
1Baghdad medical city
2Chairman of the Scientific Iraqi Council of Neurology
Abstract
Background: Behçet disease is an idiopathic chronic relapse multi-systemic vascular-inflammatory disease of unknown origin. Central nervous system involvement is considered one of the most severe manifestations of the disease, and it is categorized into primary or secondary. The primary neuro-Behçet disease can be sub-classified into parenchymal and non-parenchymal disease.

Objective: To identify neuro-Behçet disease clinical and radiological manifestations, and categorize the various presentations into characteristic patterns.

Patients and Methods: A case series study was conducted in Iraqi hospitals and outpatient clinics from March 2022 to December 2022. Demographic data of the patients and the duration of BD at the time of NBD diagnosis were recorded. The patients were clinically re-assessed for the fulfillment of Behçet disease diagnostic criteria. The enrolled patients were evaluated by neurologists in each province, for the manifestations of neuro-Behçet disease, whether current or previous presentation. Henceforth, a revision of patients' radiological reports was recorded.

Results: There were 80 patients in this study; the mean age of patients was 31.7 ± 9.1, with male predominance (62%). The mean duration of Behçet disease at neuro-Behçet diagnosis was 2.8 ± 2.4 years.

Regarding cumulative clinical manifestations, parenchymal symptoms were the most common, predominantly brainstem syndrome (67.5%). Non-parenchymal manifestations such as venous sinus thrombosis and pseudotumor cerebri presented in 46.3% of patients with Behçet disease. MRI findings reflected the clinical picture, with parenchymal involvement (55.1%) and brainstem hyperintensity being the most common (40%), followed by venous sinus thrombosis (43.8%).

Conclusion: Behçet disease neurological manifestations occurred mainly in men in their thirties to forties, and the majority of them presented within 2.8 years of Behçet disease onset. Brainstem involvement is the most common presentation. However, CVST pattern of the disease was prevalent in Iraq. Radiologically, brainstem hyperintensity is the most common finding in parenchymal NBD.
Keywords
Neuro- Behç et disease; Brainstem syndrome; cerebral venous sinus thrombosis; Behç et disease
References
  1. FEIGENBAUM A. Description of Behçet's syndrome in the Hippocratic third book of endemic diseases. Br J Ophthalmol. 1956;40:355-57.
  2. International Team for the Revision of the International Criteria for Behçet's Disease (ITR-ICBD). The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014 ;28:338-47.
  3. Yoon DL, Kim YJ, Koo BS, Kim YG, Lee CK, Yoo B, et al. Neuro-behçet's disease in South Korea: clinical characteristics and treatment response. Int J Rheum Dis. 2014;17:453-58.
 

 

 

  1. Siva A, Saip S. The spectrum of nervous system involvement in Behçet's syndrome and its differential diagnosis. J Neurol. 2009;256:513-29.
  2. Akman-Demir G, Serdaroglu P, Tasçi B. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain. 1999;122:2171-82.
  3. Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, et al. Behçet's disease: diagnostic and prognostic aspects of neurological involvement. J Neurol. 2001;248:95-103.
  4. Yesilot N, Mutlu M, Gungor O, Baykal B, Serdaroglu P, Akman-Demir G, et al. Clinical characteristics and course of spinal cord involvement in Behçet's disease. Eur J Neurol. 2007;14:729-37.
  5. Essaadouni L, Jaafari H, Abouzaid CH, Kissani N. Les manifestations neurologiques de la maladie de Behçet : étude de 67 patients [Neurological involvement in Behçet's disease: evaluation of 67 patients]. Rev Neurol (Paris). 2010;166:727-33. PMID: 20451941.
  6. Uluduz D, Midi I, Duman T, Colakoglu S, Tüfekci A, Bakar M, et al. Behçet's disease as a causative factor of cerebral venous sinus thrombosis: subgroup analysis of data from the VENOST study. Rheumatology (Oxford). 2019;58:600-8.
  7. Aguiar de Sousa D, Mestre T, Ferro JM. Cerebral venous thrombosis in Behçet's disease: a systematic review. J Neurol. 2011;258:719-27.
  8. Atasoy HT, Tunc TO, Unal AE, Emre U, Koca R, Esturk E, et al. Peripheral nervous system involvement in patients with Behçet disease. Neurologist. 2007;13:225-30.
  9. Park JH, Jung MK, Bang CO, Park HK, Sung KB, Ahn MY, et al. Neuro-Behçet's disease mimicking a cerebral tumor: a case report. J Korean Med Sci. 2002;17:718-22.
  10. Siva A. Common Clinical and Imaging Conditions Misdiagnosed as Multiple Sclerosis: A Current Approach to the Differential Diagnosis of Multiple Sclerosis. Neurol Clin. 2018;36:69-117.
 

 

  1. Lee HS, Kim do Y, Shin HY, Choi YC, Kim SM. Spinal cord involvement in Behçet's disease. Mult Scler. 2016;22:960-63.
  2. Borhani Haghighi A, Pourmand R, Nikseresht AR. Neuro-Behçet disease. A review. Neurologist. 2005;11:80-89.
  3. Al-Fahad SA, Al-Araji AH. Neuro-Behcet's disease in Iraq: a study of 40 patients. J Neurol Sci. 1999;170:105-11.
  4. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med. 1999;341:1284-91.
  5. Al-Araji A, Kidd DP. Neuro-Behçet's disease: epidemiology, clinical characteristics, and management. Lancet Neurol. 2009;8:192-204.
  6. Gökçay F, Celebisoy N, Gökçay A, Aksu K, Keser G. Neurological symptoms and signs in Behçet disease: a Western Turkey experience. Neurologist. 2011;17:147-50.
  7. Fadli ME, Youssef MM. Neuro-Behçet's syndrome in the United Arab Republic. Eur Neurol. 1973;9:76-89.
  8. Daif A, Awada A, al-Rajeh S, Abduljabbar M, al Tahan AR, Obeid T, et al. Cerebral venous thrombosis in adults. A study of 40 cases from Saudi Arabia. Stroke. 1995;26:1193-95.
  9. Wechsler B, Dell'lsola B, Vidailhet M, Dormont D, Piette JC, Blétry O, et al. MRI in 31 patients with Behçet's disease and neurological involvement: prospective study with clinical correlation. J Neurol Neurosurg Psychiatry. 1993;56:793-98.
  10. Kutlu G, Semercioglu S, Ucler S, Erdal A, Inan LE. Epileptic seizures in Neuro-Behcet disease: why some patients develop seizure and others not? Seizure. 2015;26:32-35.
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Statistics
Article View: 281
PDF Download: 164


Journal Management System. Powered by iJournalPro.com